Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-06

Clinical Trial Update: The FreMRI Study: Advanced MRI on Migraine Patients Treated With Fremanezumab [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing advanced MRI in migraine patients treated with fremanezumab; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fremanezumab (fremanezumab)

Snippet

Sponsor: Hospital Clínico Universitario de Valladolid | Conditions: Migraine Disorders, Migraine With Aura | Phase 4 | Status: UNKNOWN